Huzaifa Yasir Khan

Metal complexes of NSAIDs as potent anti-tumor chemotherapeutics: Mechanistic insights into cytotoxic activity via multiple pathways primarily by inhibition of COX–1 and COX–2 enzymes

Huzaifa Yasir Khan, Sabiha Parveen, Imtiyaz Yousuf et al. · Coordination Chemistry Reviews · 2021 · 52 citations

Medicinal Chemistry, Biochemistry, Medicine +9

Evaluation of cytotoxic potential of structurally well-characterized RNA targeted ionic non-steroidal anti-inflammatory (NSAID) Cu(<scp>ii</scp>) &amp; Zn(<scp>ii</scp>) DACH–mefenamato drug conjugates against human cancer cell lines

Huzaifa Yasir Khan, Sartaj Tabassum, Farukh Arjmand · RSC Advances · 2019 · 34 citations · Full text

Evaluation of cytotoxic activity and genotoxicity of structurally well characterized potent cobalt(II) phen–based antitumor drug entities: An in vitro and in vivo approach

Huzaifa Yasir Khan, Mohd Owais Ansari, G.G.H.A. Shadab et al. · Bioorganic Chemistry · 2019 · 23 citations

Medicinal Chemistry, Drug Targeting, Antitumor Drug Entities +9

New Tailored RNA-Targeted Organometallic Drug Candidates against Huh7 (Liver) and Du145 (Prostate) Cancer Cell Lines

Huzaifa Yasir Khan, S. Maurya, Hifzur R. Siddique et al. · ACS Omega · 2020 · 22 citations · Full text

Advances of metallodrug-amyloid β aggregation inhibitors for therapeutic intervention in neurodegenerative diseases: Evaluation of their mechanistic insights and neurotoxicity

Huzaifa Yasir Khan, Azeem Ahmad, Md Nadir Hassan et al. · Coordination Chemistry Reviews · 2023 · 19 citations

Neurodegenerative Diseases, Neurobiology Of Disease, Medicine +11